KEMPNER CAPITAL MANAGEMENT INC. recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
P O BOX 119 Galveston, TX 77553
As of the latest 13F report, the guru’s equity portfolio contained 59 stocks valued at a total of $164.00Mil. The top holdings were BSM(5.12%), CFR(4.34%), and BP(3.96%).
According to GuruFocus data, these were KEMPNER CAPITAL MANAGEMENT INC.’s top five trades of the quarter.
Viatris Inc
The guru sold out of their 516,815-share investment in NAS:VTRS. Previously, the stock had a 3.3% weight in the equity portfolio. Shares traded for an average price of $9.85 during the quarter.
On 01/13/2023, Viatris Inc traded for a price of $11.5 per share and a market cap of $13.94Bil. The stock has returned -19.84% over the past year.
GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 6 out of 10.
In terms of valuation, Viatris Inc has a price-earnings ratio of 17.42, a price-book ratio of 0.73, a EV-to-Ebitda ratio of 7.20 and a price-sales ratio of 0.84.
The price-to-GF Value ratio is 1.14, earning the stock a GF Value rank of 3.
Merck & Co Inc
The guru sold out of their 40,039-share investment in NYSE:MRK. Previously, the stock had a 2.23% weight in the equity portfolio. Shares traded for an average price of $89.27 during the quarter.
On 01/13/2023, Merck & Co Inc traded for a price of $111.51 per share and a market cap of $282.85Bil. The stock has returned 40.82% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Merck & Co Inc has a price-earnings ratio of 18.56, a price-book ratio of 6.36, a price-earnings-to-growth (PEG) ratio of 2.43, a EV-to-Ebitda ratio of 13.97 and a price-sales ratio of 4.81.
The price-to-GF Value ratio is 1.04, earning the stock a GF Value rank of 3.
Cardinal Health Inc
KEMPNER CAPITAL MANAGEMENT INC. reduced their investment in NYSE:CAH by 67,094 shares. The trade had a 2.14% impact on the equity portfolio. During the quarter, the stock traded for an average price of $63.39.
On 01/13/2023, Cardinal Health Inc traded for a price of $77.05 per share and a market cap of $20.23Bil. The stock has returned 51.25% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, Cardinal Health Inc has a EV-to-Ebitda ratio of -109.73 and a price-sales ratio of 0.11.
The price-to-GF Value ratio is 1.10, earning the stock a GF Value rank of 3.
Corteva Inc
The guru sold out of their 53,708-share investment in NYSE:CTVA. Previously, the stock had a 1.78% weight in the equity portfolio. Shares traded for an average price of $58.26 during the quarter.
On 01/13/2023, Corteva Inc traded for a price of $62.4256 per share and a market cap of $44.69Bil. The stock has returned 29.14% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 5 out of 10.
In terms of valuation, Corteva Inc has a price-earnings ratio of 33.45, a price-book ratio of 1.80, a EV-to-Ebitda ratio of 14.32 and a price-sales ratio of 2.68.
The price-to-GF Value ratio is 1.14, earning the stock a GF Value rank of 3.
Teradyne Inc
The guru established a new position worth 35,110 shares in NAS:TER, giving the stock a 1.75% weight in the equity portfolio. Shares traded for an average price of $90.96 during the quarter.
On 01/13/2023, Teradyne Inc traded for a price of $96.9 per share and a market cap of $15.10Bil. The stock has returned -38.48% over the past year.
GuruFocus gives the company a financial strength rating of 9 out of 10 and a profitability rating of 9 out of 10.
In terms of valuation, Teradyne Inc has a price-earnings ratio of 21.69, a price-book ratio of 6.70, a price-earnings-to-growth (PEG) ratio of 0.34, a EV-to-Ebitda ratio of 14.11 and a price-sales ratio of 5.05.
The price-to-GF Value ratio is 0.88, earning the stock a GF Value rank of 7.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
